COST-EFFECTIVENESS OF FERRIC CARBOXYMALTOSE FOR TREATING IRON DEFICIENCY ANEMIA IN CHINA

被引：0
|
作者：
Chuang, L. H. [1 ]
Sun, W. [2 ]
Serna, Ramirez de Arellano A. [3 ]
机构：
[1] Umea Univ, Ijsselstein, Netherlands
[2] Vifor Fresenius Kabi Beijing Pharmaceut Consultin, Beijing, Peoples R China
[3] Vifor Pharma Grp, Glattbrugg, Switzerland
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE364
引用
收藏
页码：S406 / S406
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF FERRIC CARBOXYMALTOSE IN THE TREATMENT OF IRON-DEFICIENCY ANEMIA IN PREGNANT WOMEN
    Alves, Junior J. M.
    Prota, F. E.
    Martinelli, J. C. B.
    Chrispim, A.
    Christoforo, F. F.
    Serpeloni, M.
    Barreto, I
    da Silva, A. C.
    VALUE IN HEALTH, 2024, 27 (06) : S104 - S104
  • [2] COST-EFFECTIVENESS OF FERRIC CARBOXYMALTOSE (FCM) IN THE TREATMENT OF IRON DEFICIENCY ANEMIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)
    Walter, E.
    Lazic-Peric, A.
    Schalle, K.
    VALUE IN HEALTH, 2017, 20 (09) : A634 - A635
  • [3] COST-EFFECTIVENESS OF FERRIC CARBOXYMALTOSE IN PATIENTS WITH IRON DEFICIENCY AND CHRONIC HEART FAILURE IN AUSTRIA
    Walter, E.
    Bauer, M.
    Ressl, S.
    VALUE IN HEALTH, 2015, 18 (07) : A392 - A392
  • [4] Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia
    Mikio Momoeda
    Kyoko Ito
    Sachie Inoue
    Hidetoshi Shibahara
    Yuko Mitobe
    Norio Komatsu
    International Journal of Hematology, 2025, 121 (4) : 467 - 475
  • [5] COST-EFFECTIVENESS ANALYSIS OF FERRIC CARBOXYMALTOSE VERSUS IRON SUCROSE FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN SPAIN
    Arguelles, F.
    Bermejo, F.
    Borras Blasco, J.
    Domenech, E.
    Sicilia, B.
    Huguet, J. M.
    Serna, Ramirez de Arellano A.
    Valentine, W.
    Hunt, B.
    VALUE IN HEALTH, 2022, 25 (01) : S95 - S95
  • [6] A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom
    Pollock, Richard F.
    Muduma, Gorden
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (07) : 751 - 759
  • [7] Cost-effectiveness analysis of ferric carboxymaltose versus iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain
    Arguelles-Arias, Federico
    Bermejo, Fernando
    Borras-Blasco, Joaquin
    Domenech, Eugeni
    Sicilia, Beatriz
    Huguet, Jose M.
    de Arellano, Antonio Ramirez
    Valentine, William J.
    Hunt, Barnaby
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [8] A PATIENT-LEVEL COST-EFFECTIVENESS ANALYSIS OF IRON ISOMALTOSIDE VERSUS FERRIC CARBOXYMALTOSE FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA IN THE UNITED KINGDOM
    Pollock, R.
    Muduma, G.
    VALUE IN HEALTH, 2020, 23 : S373 - S373
  • [9] A COST-UTILITY ANALYSIS OF FERRIC DERISOMALTOSE VERSUS FERRIC CARBOXYMALTOSE IN PATIENTS WITH IRON DEFICIENCY ANEMIA IN CHINA
    Zhang, F.
    Shen, A.
    Ahmed, W.
    Pollock, R.
    VALUE IN HEALTH, 2023, 26 (12) : S102 - S103
  • [10] A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China
    Zhang, Fengkui
    Shen, Aizong
    Ahmed, Waqas
    Pollock, Richard F.
    ADVANCES IN THERAPY, 2024, 41 (11) : 4191 - 4204
12345